Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

1,530

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

MeaslesRubellaYellow Fever

Interventions

BIOLOGICAL

Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd

Live attenuated vaccine

BIOLOGICAL

Yellow fever Vaccine (WHO prequalified)

Live attenuated vaccine

Trial Locations (1)

Icddr,B, Dhaka

All Listed Sponsors

collaborator

Zydus Lifesciences Limited

INDUSTRY

lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER